AdvisorShares Psychedelics ETF Rating $16.32 +0.55 (+3.49%) As of 03:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PSIL Aggregate RatingBuy 3.03Holdings in PSIL have an aggregate rating of Buy based on 79 analyst ratings issued in the past year covering 13 companies (69.9% of the portfolio).PSIL Aggregate Price Target$16.23High Prediction$16.23Average Prediction$16.23Low Prediction$16.23Holdings in PSIL have an aggregate price target of $16.23 and a range of $16.23 to $16.23 covering 13 companies (69.9% of the portfolio).PSIL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy5 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by AdvisorShares Psychedelics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 13 PSIL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings13.32%ATAIatai Life Sciences$4.45+12.0%2.8335 of 5 stars3.40$11.25 153.1%5Earnings ReportAnalyst Revision9.01%MNMDMind Medicine (MindMed)$9.89+4.7%2.7165 of 5 stars3.22$24.71 149.9%96.83%CMPSCOMPASS Pathways$4.38+7.2%2.7147 of 5 stars2.86$16.29 272.2%75.71%ALKSAlkermes$29.05+0.3%4.7867 of 5 stars2.83$41.08 41.4%12Positive NewsAnalyst Revision5.34%NRXPNRx Pharmaceuticals$2.59-1.3%3.1039 of 5 stars3.20$28.50 1,002.5%5Earnings ReportAnalyst ForecastShort Interest ↓5.19%STIMNeuronetics$3.41+2.3%2.3635 of 5 stars3.00$7.00 105.6%1Positive News5.06%GHRSGH Research$12.82+0.3%3.0065 of 5 stars2.88$32.00 149.6%8Positive News4.82%NBIXNeurocrine Biosciences$135.25+1.5%4.8535 of 5 stars2.86$159.50 17.9%21Positive News4.57%VTGNVistaGen Therapeutics$3.09-0.5%1.5311 of 5 stars3.0014.32%NEUPNeuphoria Therapeutics$6.90-0.6%1.3431 of 5 stars3.00$21.00 204.3%12.86%SUPNSupernus Pharmaceuticals$43.47+1.8%2.0954 of 5 stars2.50$41.00 -5.7%4News CoverageAnalyst UpgradeInsider Trade1.96%RLMDRelmada Therapeutics$0.61-0.9%4.2196 of 5 stars2.25$5.00 723.7%40.88%ENVBEnveric Biosciences$1.17+0.9%2.2721 of 5 stars3.00$10.00 754.7%1Positive NewsEarnings Report This page (NYSEARCA:PSIL) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access